Dr. Zimmerman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4020 N Roxboro St
Durham, NC 27704Phone+1 919-681-3009Fax+1 919-620-4921
Education & Training
Duke University HospitalFellowship, Pediatric Critical Care Medicine, 2012 - 2015- Duke University HospitalResidency, Internal Medicine/Pediatrics, 2007 - 2011
Duke University School of MedicineClass of 2007
Certifications & Licensure
NC State Medical License 2007 - 2025- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Critical Care Medicine
Clinical Trials
- Pharmacokinetics of Dexmedetomidine in Children During Cardiopulmonary Bypass (CPB) Start of enrollment: 2014 Mar 01
- Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH) Start of enrollment: 2017 May 05
- Pharmacokinetics of Anti-epileptic Drugs in Obese Children Start of enrollment: 2016 Dec 09
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsPharmacokinetic, efficacy, and safety considerations for the use of antifungal drugs in the neonatal population.Briana Scott, Chi D. Hornik, Kanecia O. Zimmerman
Expert Opinion on Drug Metabolism & Toxicology. 2020-06-07 - 149 citationsIncidence and Secondary Transmission of SARS-CoV-2 Infections in Schools.Kanecia O. Zimmerman, Ibukunoluwa C. Akinboyo, M. Alan Brookhart, Angelique E Boutzoukas, Kathleen A. McGann
Pediatrics. 2021-04-01 - 38 citationsSedation, Analgesia, and Paralysis during Mechanical Ventilation of Premature InfantsKanecia O. Zimmerman, P. Brian Smith, Daniel K. Benjamin, Matthew M. Laughon, Reese H. Clark
The Journal of Pediatrics. 2017-01-01
Journal Articles
- Incidence and Secondary Transmission of SARS-CoV-2 Infections in SchoolsKanecia Zimmerman, MD, Pediatrics
- Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients with Coronavirus Disease 2019Kanecia Zimmerman, MD, JAMA Pediatrics
- Duration of Pediatric Clinical Trials Submitted to the US Food and Drug AdministrationP Brian Smith, Kanecia O Zimmerman, JAMA
Press Mentions
What Is Long COVID and Who’s at Risk? This NIH Project May Find OutOctober 24th, 2022- No More Guessing: Duke Pediatric Experts Build Unique Foundation to Find the Right Dose for ChildrenSeptember 14th, 2022
- Study: Masking Greatly Reduces COVID-19 Spread in SchoolsMarch 9th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
